Skip to main
TRLV

TRLV Stock Forecast & Price Target

TRLV Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Trulieve Cannabis is a market-leading and vertically integrated company operating in multiple states, including Florida, Arizona, and Pennsylvania. They have a strong and evolving presence in the fast-growing cannabis market, with expansion opportunities in key states, such as Georgia and Texas, where final licensing approval could greatly increase their operations. The company's multiple federal regulatory catalysts, including DEA rescheduling, could further boost their growth potential. Additionally, Trulieve has a unique competitive advantage with its AI-driven customer engagement initiatives and a strong loyalty program, which could drive increased sales and profitability. Based on these factors, the current valuation for TRLV appears to be attractive, and their continued focus on expanding their market share and retail footprint should lead to continued success.

Bears say

Trulieve Cannabis is facing potential regulatory hurdles as the company expands into additional markets. Although it currently holds a strong market position in Florida, the company may face challenges in converting the larger unregulated hemp market into regulated medical use. While Trulieve has reported strong financial results and is poised for future growth, any delays or restrictions in state-level legislative and regulatory changes could negatively impact the company's operations and long-term growth prospects.

TRLV has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Trulieve Cannabis Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Trulieve Cannabis Corp (TRLV) Forecast

Analysts have given TRLV a Buy based on their latest research and market trends.

According to 1 analysts, TRLV has a Buy consensus rating as of Sep 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Trulieve Cannabis Corp (TRLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.